| Source HCPCS Code |
|
Target NDC Code |
J2356
Inj tezepelumab-ekko, 1mg
|
⇄
|
55513-0112-01
TEZSPIRE 210 MG/1.91 ML SYRING
|
| Detail Information |
| Relationship Start Date |
07/01/2022 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1.91 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
J2356
Inj tezepelumab-ekko, 1mg
|
⇄
|
55513-0123-01
TEZSPIRE 210 MG/1.91 ML PEN
|
| Detail Information |
| Relationship Start Date |
01/01/2023 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
1.91 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
J2356
Inj tezepelumab-ekko, 1mg
|
⇄
|
55513-0112-01
Tezspire
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
J2356
Inj tezepelumab-ekko, 1mg
|
⇄
|
55513-0123-01
TEZSPIRE
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|